Form 8-K - Current report:
SEC Accession No. 0000950170-22-000835
Filing Date
2022-02-07
Accepted
2022-02-07 16:31:48
Documents
15
Period of Report
2022-02-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20220207.htm   iXBRL 8-K 58107
2 EX-10.1 alec-ex10_1.htm EX-10.1 53001
3 EX-99.1 alec-ex99_1.htm EX-99.1 16941
4 GRAPHIC img142868347_0.jpg GRAPHIC 16944
  Complete submission text file 0000950170-22-000835.txt   281919

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20220207_lab.xml EX-101.LAB 13448
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20220207.xsd EX-101.SCH 2480
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20220207_pre.xml EX-101.PRE 9929
9 EXTRACTED XBRL INSTANCE DOCUMENT alec-20220207_htm.xml XML 4688
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 22597789
SIC: 2836 Biological Products, (No Diagnostic Substances)